Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Current Leases (2020 - 2025)

Historic Current Leases for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $2.6 million.

  • SOPHiA GENETICS's Current Leases rose 532.9% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 532.9%. This contributed to the annual value of $2.2 million for FY2024, which is 2520.49% down from last year.
  • Per SOPHiA GENETICS's latest filing, its Current Leases stood at $2.6 million for Q3 2025, which was up 532.9% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Current Leases registered a high of $3.5 million during Q2 2023, and its lowest value of $967000.0 during Q2 2021.
  • Moreover, its 5-year median value for Current Leases was $2.5 million (2024), whereas its average is $2.4 million.
  • In the last 5 years, SOPHiA GENETICS's Current Leases skyrocketed by 10206.83% in 2022 and then crashed by 2588.0% in 2024.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Current Leases stood at $1.8 million in 2021, then skyrocketed by 48.37% to $2.7 million in 2022, then increased by 8.85% to $2.9 million in 2023, then decreased by 25.2% to $2.2 million in 2024, then grew by 19.13% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.5 million for Q2 2025, and $2.3 million during Q1 2025.